These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20041836)

  • 1. Mechanisms involved in the genesis of diabetic nephropathy.
    Blázquez-Medela AM; López-Novoa JM; Martínez-Salgado C
    Curr Diabetes Rev; 2010 Mar; 6(2):68-87. PubMed ID: 20041836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy in insulin-dependent diabetes mellitus: pathogenesis and treatment strategies.
    Bilo HJ; Gans RO; Elving L; de Nobel E; Donker AJ
    Neth J Med; 1990 Feb; 36(1-2):74-85. PubMed ID: 2179753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances concerning the pathogenesis of diabetic nephropathy].
    Scarpioni L
    Minerva Urol Nefrol; 1985; 37(1):5-8. PubMed ID: 3901336
    [No Abstract]   [Full Text] [Related]  

  • 5. [Natural history of diabetic nephropathy].
    Ishimura E
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():324-30. PubMed ID: 15999728
    [No Abstract]   [Full Text] [Related]  

  • 6. Rodent animal models: from mild to advanced stages of diabetic nephropathy.
    Kaur M; Bedi O; Sachdeva S; Reddy BV; Kumar P
    Inflammopharmacology; 2014 Oct; 22(5):279-93. PubMed ID: 25149089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal profile of diabetic nephropathy pathologic changes.
    Ponchiardi C; Mauer M; Najafian B
    Curr Diab Rep; 2013 Aug; 13(4):592-9. PubMed ID: 23712652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 Inhibitors and the Diabetic Kidney.
    Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
    Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic nephropathy].
    Weekers L; Krzesinski JM
    Rev Med Liege; 2005; 60(5-6):479-86. PubMed ID: 16041860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet therapy in diabetic nephropathy.
    Maeda Y; Shiigai T
    Contrib Nephrol; 2007; 155():50-58. PubMed ID: 17369713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of diabetic nephropathy: a rational approach based on its pathophysiology.
    Tuttle KR; DeFronzo RA; Stein JH
    Semin Nephrol; 1991 Mar; 11(2):220-35. PubMed ID: 1674623
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases.
    Liu S; Guo Q; Han H; Cui P; Liu X; Miao L; Zou H; Sun G
    Int Urol Nephrol; 2016 Oct; 48(10):1691-8. PubMed ID: 27272256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
    Bruce R; Williams L; Cundy T
    Aust N Z J Med; 1994 Aug; 24(4):390-5. PubMed ID: 7980236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy.
    Doi T; Moriya T; Fujita Y; Minagawa N; Usami M; Sasaki T; Abe H; Kishi S; Murakami T; Ouchi M; Ichien G; Yamamoto K; Ikeda H; Koezuka Y; Takamatsu N; Shima K; Mauer M; Nagai K; Tominaga T
    Diabetes; 2018 May; 67(5):986-993. PubMed ID: 29490904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy.
    Zhuo L; Zhang N; Zou G; Chen D; Li W
    Front Med; 2017 Sep; 11(3):386-392. PubMed ID: 28871455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic nephropathy in children and adolescents.
    Bogdanović R
    Pediatr Nephrol; 2008 Apr; 23(4):507-25. PubMed ID: 17940807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients.
    Dong Z; Wang Y; Qiu Q; Zhang X; Zhang L; Wu J; Wei R; Zhu H; Cai G; Sun X; Chen X
    Diabetes Res Clin Pract; 2016 Nov; 121():112-118. PubMed ID: 27693840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic nephropathy of type 1 diabetes mellitus.
    Mironidou-Tzouveleki M; Tsartsalis S; Tomos C
    Curr Drug Targets; 2011 Jan; 12(1):107-14. PubMed ID: 20735351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does body mass index influence the decline of glomerular filtration rate in diabetic type 2 patients with diabetic nephropathy in a developing country?
    Bentata Y; Latrech H; Abouqal R
    Ren Fail; 2014 Jul; 36(6):838-46. PubMed ID: 24673339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.